Longitudinal Monitoring for the Emergence of Epidermal Growth Factor C797S Resistance Mutations in Non-Small Cell Lung Cancer Using Blood-Based Droplet Digital PCR
Bowling, Mark R., & Arastu, Hyder, & Walker, Paul. (January 2019).
Longitudinal Monitoring for the Emergence of Epidermal Growth Factor C797S Resistance Mutations in Non-Small Cell Lung Cancer Using Blood-Based Droplet Digital PCR.
Cancer Drug Resistance,
(2:3), p.912-916. Retrieved from
http://hdl.handle.net/10342/10498
Bowling, Mark R., and Arastu, Hyder, and Walker, Paul.
"Longitudinal Monitoring for the Emergence of Epidermal Growth Factor C797S Resistance Mutations in Non-Small Cell Lung Cancer Using Blood-Based Droplet Digital PCR". Cancer Drug Resistance.
2:3. (912-916.),
January 2019.
May 20, 2022.
http://hdl.handle.net/10342/10498.
Chicago:
Bowling, Mark R. and Arastu, Hyder and Walker, Paul,
"Longitudinal Monitoring for the Emergence of Epidermal Growth Factor C797S Resistance Mutations in Non-Small Cell Lung Cancer Using Blood-Based Droplet Digital PCR," Cancer Drug Resistance 2, no.
3 (January 2019),
http://hdl.handle.net/10342/10498 (accessed
May 20, 2022).
AMA:
Bowling, Mark R., Arastu, Hyder, Walker, Paul.
Longitudinal Monitoring for the Emergence of Epidermal Growth Factor C797S Resistance Mutations in Non-Small Cell Lung Cancer Using Blood-Based Droplet Digital PCR. Cancer Drug Resistance.
January 2019;
2(3)
912-916. http://hdl.handle.net/10342/10498. Accessed
May 20, 2022.
